Lansoprazole Capsule, Delayed Release
Product Images NDC 68071-2734

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68071-2734). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2734 6)

Pdp (68071 2734 6)
Label for Lansoprazole 15 mg delayed-release capsules by NuCare Pharmaceuticals, Inc. The label states the product contains 60 capsules with pink caps and green bodies, each imprinted with 'H' on the cap and '166' on the body. Manufactured by Hetero Labs Limited, India, the label includes storage instructions and FDA reporting information.*
FDA Label Image

Lansoprazolefigure1 (Lansoprazolefigure1)

Lansoprazolefigure1 (Lansoprazolefigure1)
A line graph depicting mean severity of day heartburn over time for evaluable patients, comparing placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. The x-axis shows days from start of treatment, and the y-axis represents mean severity (0=None to 3=Severe). Both Lansoprazole groups demonstrate lower severity than placebo over approximately 60 days.*
FDA Label Image

Lansoprazolefigure2 (Lansoprazolefigure2)

Lansoprazolefigure2 (Lansoprazolefigure2)
A line graph titled 'Mean Severity of Night Heartburn By Study Day For Evaluable Patients,' showing mean severity scores for placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD groups over 60 days of treatment. The x-axis represents days from start of treatment, and the y-axis shows mean severity of night heartburn with scores from 0 to 3, where 3 is severe.*
FDA Label Image

Lansoprazolestructure (Lansoprazolestructure)

Lansoprazolestructure (Lansoprazolestructure)
Chemical structure diagram of the active ingredient lansoprazole, showing its molecular conformation with rings, sulfoxide group, and trifluoromethyl side chain.*
FDA Label Image

Camber (Camber)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.